| 789198 |
THERANOSTICS |
Ion drugs for precise orthotopic tumor management by in situ the generation of toxic ion and drug pools |
2022-01-01 |
10.7150/thno.66468 |
Feng Yushuo, Qin Ruixue, Xu Lihua, Ma Xiaoqian, Ding Dandan, Li Shi, Chen Lei, Liu Yaqing, Sun Wenjing, Chen Hongmin |
| 789197 |
THERANOSTICS |
5-aza-2′-deoxycytidine potentiates anti-tumor immunity in colorectal peritoneal metastasis by modulating ABC A9-mediated cholesterol accumulation in macrophages |
2022-01-01 |
10.7150/thno.66420 |
Shi Rongchen, Zhao Kun, Wang Teng, Yuan Jing, Zhang Dapeng, Xiang Wei, Qian Jin, Luo Na, Zhou Yong, Tang Bo, Li Chuan, Miao Hongming |
| 789196 |
THERANOSTICS |
Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation |
2022-01-01 |
10.7150/thno.66274 |
Vultaggio-Poma Valentina, Falzoni Simonetta, Chiozzi Paola, Sarti Alba Clara, Adinolfi Elena, Giuliani Anna Lisa, Sánchez-Melgar Alejandro, Boldrini Paola, Zanoni Michele, Tesei Anna, Pinton Paolo, Di Virgilio Francesco |
| 789195 |
THERANOSTICS |
Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling |
2022-01-01 |
10.7150/thno.66148 |
Sun Xun, Li Kexin, Hase Misato, Zha Rongrong, Feng Yan, Li Bai-Yan, Yokota Hiroki |
| 789194 |
THERANOSTICS |
Dysregulation of interaction between LOXhigh fibroblast and smooth muscle cells contributes to the pathogenesis of aortic dissection |
2022-01-01 |
10.7150/thno.66059 |
Chen Yinan, Zhang Tao, Yao Fang, Gao Xiang, Li Dandan, Fu Shufang, Mao Lin, Liu Fei, Zhang Xuelin, Xu Yongle, Deng Jianqing, Li Weihao, Fan Guangpu, Xiao Cangsong, Chen Yu, Wang Li, Guo Wei, Zhou Bingying |
| 789193 |
THERANOSTICS |
Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells |
2022-01-01 |
10.7150/thno.65828 |
Tu Jingyao, Xu Haoran, Ma Li, Li Chunya, Qin Wan, Chen Xinyi, Yi Ming, Sun Li, Liu Bo, Yuan Xianglin |
| 789192 |
THERANOSTICS |
Loss of function of GATA3 induces basal-like mammary tumors |
2022-01-01 |
10.7150/thno.65796 |
Bai Feng, Zheng Chenglong, Liu Xiong, Chan Ho Lam, Liu Shiqin, Ma Jinshan, Ren Sijia, Zhu Wei-Guo, Pei Xin-Hai |
| 789191 |
THERANOSTICS |
Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival |
2022-01-01 |
10.7150/thno.65773 |
Liu Kaili, Hoover Ashley R., Krawic Jason R., DeVette Christa I., Sun Xiao-Hong, Hildebrand William H., Lang Mark L., Axtell Robert C., Chen Wei R. |
| 789190 |
THERANOSTICS |
Comprehensive omics analyses profile genesets related with tumor heterogeneity of multifocal glioblastomas and reveal LIF/CCL2 as biomarkers for mesenchymal subtype |
2022-01-01 |
10.7150/thno.65739 |
Lv Sheng-Qing, Fu Zhen, Yang Lin, Li Qing-Rui, Zhu Jiang, Gai Qu-Jing, Mao Min, He Jiang, Qin Yan, Yao Xiao-Xue, Lan Xi, Wang Yan-Xia, Lu Hui-Min, Xiang Yan, Zhang Zuo-Xin, Huang Guo-Hao, Yang Wei, Kang Ping, Sun Zhijian, Shi Yu, Yao Xiao-Hong, Bian Xiu-Wu, Wang Yan |
| 789189 |
THERANOSTICS |
HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment |
2022-01-01 |
10.7150/thno.65411 |
Wang Xin, Wang Jian, Zhao Jiahui, Wang Hao, Chen Jing, Wu Jingjing |
